Consistently, the soluble serum tumor markers, the HER2 expression as well as other common genetic and molecular markers (MSI, KRAS, NRAS, BRAF, PIK3CA, p53) did not show a significant difference between B7-H3 expression levels. This evidence concerns the gene ERBB2 and neoplasm.